CAS 849217-64-7 appears in our catalog under these names: Foretinib, 95%, Foretinib, Foretinib/ 99.7% (existing batch purity), Foretinib (GSK1363089), Foretinib 98%. Offered by: Combi-blocks, Chemat Brand, TRC, TargetMol, GLPBio. Available pack sizes: 100mg, 250mg, 1g, on request, 25mg, 50mg, 2mg, 5mg.
Foretinib is a quinoline substituted by 2-fluoro-4-[({1-[(4-fluorophenyl)carbamoyl]cyclopropyl}carbonyl)amino]phenoxy, methoxy, and 3-(morpholin-4-yl)propoxy groups at positions 4, 6 and 7, respectively. It is a multi-kinase inhibitor. It has a role as an antineoplastic agent, a vascular endothelial growth factor receptor antagonist, an apoptosis inducer and a c-Met tyrosine kinase inhibitor. It is a member of quinolines, an aromatic ether, a dicarboxylic acid diamide, a member of morpholines, a member of cyclopropanes and a member of monofluorobenzenes.
Source: ChEBI
| Molecular formula | C34H34F2N4O6 |
|---|---|
| Molecular weight | 632.7 g/mol |
| IUPAC name | 1-N'-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
| InChIKey | CXQHYVUVSFXTMY-UHFFFAOYSA-N |
| SMILES | COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F |
Computed by PubChem (NCBI)